Rozenman Mary M.
Related Filers (1)
Ownership (17)
5
Friday, 2/14/2020
Aimmune Therapeutics, Inc.: Annual statement of changes in beneficial ownership of securities
4
Tuesday, 2/26/2019
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/6/2018
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/5/2018
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/5/2018
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/4/2018
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/28/2017
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/11/2017
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/17/2017
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/6/2017
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/24/2017
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/6/2016
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/4/2016
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/7/2016
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/9/2016
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/26/2016
Aimmune Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 8/5/2015
Aimmune Therapeutics, Inc.: Initial statement of beneficial ownership of securities